Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,goodWill,treasuryStock,cash,totalCurrentLiabilities,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,netReceivables,inventory,accountsPayable,changeToLiabilities,changeToOperatingActivities,changeInCash,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToAccountReceivables,changeToNetincome,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,issuanceOfStock,WC,language,region,quoteType,triggerable,quoteSourceName,market,currency,twoHundredDayAverageChangePercent,exchangeDataDelayedBy,marketState,exchange,esgPopulated,tradeable,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,priceHint,preMarketChange,preMarketChangePercent,preMarketTime,preMarketPrice,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,gmtOffSetMilliseconds,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,marketCap,shortName,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (Apr 29, 2021) 4","Short Ratio (Apr 29, 2021) 4","Short % of Float (Apr 29, 2021) 4","Short % of Shares Outstanding (Apr 29, 2021) 4","Shares Short (prior month Mar 30, 2021) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,industry,address2
t0,JUPW,2971146.0,11260200,,,-2195763,,-2195763,2888294,25394,-2862900,-2862900,,-3341,,,,0,48846,2911746,23452,667137,,-2195763,-2195763,518097.0,13554234.0,650755.0,4431180.0,5081935.0,11260.0,23622.0,-9470164.0,941937.0,335850.0,3007792.0,650755.0,335850.0,33392.0,3588509.0,12665.0,249321.0,453328.0,-245508.0,-67463.0,-1254376.0,-1254376.0,21603.0,-23397.0,242446.0,1013706.0,,,,,2937754.0,en-US,US,EQUITY,True,Delayed Quote,us_market,USD,-0.5609781,0,PRE,NCM,False,False,1.82,1630526402,0.0200001,1.8,1.88,1.76,604112,15,America/New_York,EDT,4,-0.01000011,-0.54945654,1630573004,1.81,1.1111168,1.76 - 1.88,1.8,0.0,0.0,11,9,finmb_605168051,NasdaqCM,"Jupiter Wellness, Inc.",USD,546670,447085,0.2800001,0.18181825,1.54 - 8.88,-7.06,-0.795045,1.54,8.88,-14400000,2.1805713,-0.36057127,-0.16535632,4.14558,-2.3255796,20493564,"Jupiter Wellness, Inc.",,,,8.88,1.54,2.1806,4.1456,546.67k,447.08k,11.26M,,5.74M,41.94%,18.56%,209.28k,1.55,3.44%,1.86%,187.34k,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",0.00%,-755.79%,-132.32%,-353.16%,996.78k,0.12,-58.50%,441.1k,-7.42M,-8M,,,3.01M,0.27,109.18k,2.46,5.51,,-3.53M,-1.93M,Value,33477,Healthcare,5,"Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for use in the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CaniSun, a CBD-infused sunscreen; and CaniSkin, a CBD-infused skin care lotion. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.",Jupiter,561 244 7100,FL,1609372800,United States,http://www.jupiterwellnessinc.com,86400,725 North Highway A1A,Drug Manufacturers—Specialty & Generic,Suite C-106
t-1,JUPW,2891804.0,11260200,,,-4766743,,-4766743,3722047,120671,-3704768,-3704768,,-22711,,,,0,311936,4016704,191265,-1061975,,-4766743,-4766743,559800.0,11657286.0,2132052.0,4393541.0,6525593.0,10656.0,152273.0,-7274401.0,941937.0,,4262168.0,2125668.0,,35592.0,4988264.0,255111.0,225924.0,688835.0,3741.0,1009689.0,4131055.0,-1417636.0,32367.0,116827.0,-75537.0,2247495.0,43405.0,-800000.0,5505286.0,6305286.0,2862596.0,en-US,US,EQUITY,True,Delayed Quote,us_market,USD,-0.5609781,0,PRE,NCM,False,False,1.82,1630526402,0.0200001,1.8,1.88,1.76,604112,15,America/New_York,EDT,4,-0.01000011,-0.54945654,1630573004,1.81,1.1111168,1.76 - 1.88,1.8,0.0,0.0,11,9,finmb_605168051,NasdaqCM,"Jupiter Wellness, Inc.",USD,546670,447085,0.2800001,0.18181825,1.54 - 8.88,-7.06,-0.795045,1.54,8.88,-14400000,2.1805713,-0.36057127,-0.16535632,4.14558,-2.3255796,20493564,"Jupiter Wellness, Inc.",,,,8.88,1.54,2.1806,4.1456,546.67k,447.08k,11.26M,,5.74M,41.94%,18.56%,209.28k,1.55,3.44%,1.86%,187.34k,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",0.00%,-755.79%,-132.32%,-353.16%,996.78k,0.12,-58.50%,441.1k,-7.42M,-8M,,,3.01M,0.27,109.18k,2.46,5.51,,-3.53M,-1.93M,Value,33477,Healthcare,5,"Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for use in the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CaniSun, a CBD-infused sunscreen; and CaniSkin, a CBD-infused skin care lotion. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.",Jupiter,561 244 7100,FL,1609372800,United States,http://www.jupiterwellnessinc.com,86400,725 North Highway A1A,Drug Manufacturers—Specialty & Generic,Suite C-106
t-2,JUPW,-1983982.0,11260200,,,-607289,,-607289,650412,81727,-568685,-568685,,-39672,,,,0,178335,747020,96608,-38604,,-607289,-607289,884295.0,1264768.0,2556982.0,-790997.0,1765985.0,6893.0,37755.0,-2507658.0,308690.0,445000.0,131113.0,2526844.0,445000.0,37792.0,535208.0,22481.0,293859.0,7768.0,0.0,2460.0,-170755.0,-465755.0,32366.0,-35304.0,24002.0,103486.0,43405.0,250000.0,295000.0,45000.0,-1991636.0,en-US,US,EQUITY,True,Delayed Quote,us_market,USD,-0.5609781,0,PRE,NCM,False,False,1.82,1630526402,0.0200001,1.8,1.88,1.76,604112,15,America/New_York,EDT,4,-0.01000011,-0.54945654,1630573004,1.81,1.1111168,1.76 - 1.88,1.8,0.0,0.0,11,9,finmb_605168051,NasdaqCM,"Jupiter Wellness, Inc.",USD,546670,447085,0.2800001,0.18181825,1.54 - 8.88,-7.06,-0.795045,1.54,8.88,-14400000,2.1805713,-0.36057127,-0.16535632,4.14558,-2.3255796,20493564,"Jupiter Wellness, Inc.",,,,8.88,1.54,2.1806,4.1456,546.67k,447.08k,11.26M,,5.74M,41.94%,18.56%,209.28k,1.55,3.44%,1.86%,187.34k,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",0.00%,-755.79%,-132.32%,-353.16%,996.78k,0.12,-58.50%,441.1k,-7.42M,-8M,,,3.01M,0.27,109.18k,2.46,5.51,,-3.53M,-1.93M,Value,33477,Healthcare,5,"Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for use in the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CaniSun, a CBD-infused sunscreen; and CaniSkin, a CBD-infused skin care lotion. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.",Jupiter,561 244 7100,FL,1609372800,United States,http://www.jupiterwellnessinc.com,86400,725 North Highway A1A,Drug Manufacturers—Specialty & Generic,Suite C-106
t-3,JUPW,-1555345.0,11260200,39463.0,,-433375,,-433375,514157,220873,-361105,-361105,,-72339,,,,0,457667,818772,236794,-72270,,-433375,-433375,914461.0,1236282.0,2295455.0,-332194.0,1963261.0,6893.0,43212.0,-1900369.0,308690.0,325000.0,301868.0,2265317.0,325000.0,39992.0,700118.0,46483.0,258555.0,7768.0,-15418.0,118639.0,-57129.0,-391707.0,32366.0,-93863.0,-14423.0,103486.0,43405.0,334578.0,334578.0,45000.0,-1565199.0,en-US,US,EQUITY,True,Delayed Quote,us_market,USD,-0.5609781,0,PRE,NCM,False,False,1.82,1630526402,0.0200001,1.8,1.88,1.76,604112,15,America/New_York,EDT,4,-0.01000011,-0.54945654,1630573004,1.81,1.1111168,1.76 - 1.88,1.8,0.0,0.0,11,9,finmb_605168051,NasdaqCM,"Jupiter Wellness, Inc.",USD,546670,447085,0.2800001,0.18181825,1.54 - 8.88,-7.06,-0.795045,1.54,8.88,-14400000,2.1805713,-0.36057127,-0.16535632,4.14558,-2.3255796,20493564,"Jupiter Wellness, Inc.",,,,8.88,1.54,2.1806,4.1456,546.67k,447.08k,11.26M,,5.74M,41.94%,18.56%,209.28k,1.55,3.44%,1.86%,187.34k,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",0.00%,-755.79%,-132.32%,-353.16%,996.78k,0.12,-58.50%,441.1k,-7.42M,-8M,,,3.01M,0.27,109.18k,2.46,5.51,,-3.53M,-1.93M,Value,33477,Healthcare,5,"Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for use in the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CaniSun, a CBD-infused sunscreen; and CaniSkin, a CBD-infused skin care lotion. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.",Jupiter,561 244 7100,FL,1609372800,United States,http://www.jupiterwellnessinc.com,86400,725 North Highway A1A,Drug Manufacturers—Specialty & Generic,Suite C-106
